Prime Therapeutics, a pharmacy benefit manager owned by several Blue Cross and Blue Shield health insurers, promoted Mostafa Kamal to succeed the retiring Ken Paulus as chief executive officer.The new leadership at Prime comes following the PBM’s $1.35 billion acquisition of MagellanRx Management, which was formerly part of Magellan Health, and divested in December by […]
